Lancet Neurol: When the Risk of Intracranial Hemorrhage Exceeds Ischemic Stroke in Patients with Cerebral Microbleeds, Antithrombotic Therapy or not?

doi:10.3969/j.issn.1673-5765.2019.11.016

Chinese Journal of Stroke ›› 2019, Vol. 14 ›› Issue (11): 1172-1172.DOI: 10.3969/j.issn.1673-5765.2019.11.016

Previous Articles Next Articles

Lancet Neurol: When the Risk of Intracranial Hemorrhage Exceeds Ischemic Stroke in Patients with Cerebral Microbleeds, Antithrombotic Therapy or not?

Online:2019-11-20 Published:2019-11-20

Lancet Neurol：脑微出血者缺血风险大于出血风险，该不该抗栓？

杨中华

100070 北京首都医科大学附属北京天坛医院神经病学中心，脑血管病中心，神经重症医学科

通讯作者: 杨中华 rhammer@163.com

Abstract

YANG Zhong-Hua. Lancet Neurol: When the Risk of Intracranial Hemorrhage Exceeds Ischemic Stroke in Patients with Cerebral Microbleeds, Antithrombotic Therapy or not?[J]. Chinese Journal of Stroke, 2019, 14(11): 1172-1172.

杨中华. Lancet Neurol：脑微出血者缺血风险大于出血风险，该不该抗栓？[J]. 中国卒中杂志, 2019, 14(11): 1172-1172.

Lancet Neurol: When the Risk of Intracranial Hemorrhage Exceeds Ischemic Stroke in Patients with Cerebral Microbleeds, Antithrombotic Therapy or not?

Lancet Neurol：脑微出血者缺血风险大于出血风险，该不该抗栓？

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics